Thursday, July 17, 2025 10:38:27 AM
Despite successful delivery and operational confirmation on their side, a significant portion of the payment remains outstanding to this day, with no clear settlement timeline or satisfactory response from the company.
We are currently reviewing legal and regulatory pathways for formal resolution, including outreach to relevant U.S. oversight bodies and legal counsel.
If any other vendors, partners, or service providers have experienced similar difficulties with delayed or non-payment by iSpecimen Inc., we encourage you to reach out for confidential coordination.
This message is shared solely for the purpose of transparency and factual documentation of unresolved obligations.
We reserve all rights under applicable commercial and contract law. info@ukrainebiobank,com
Recent ISPC News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 09:00:30 PM
- Nasdaq Microcap Soars After Unveiling AI Tool Designed to Accelerate Medical Research • AllPennyStocks.com • 03/13/2026 06:20:57 PM
- iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching • GlobeNewswire Inc. • 03/12/2026 08:05:00 PM
- iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching • Newsfile • 03/12/2026 08:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/03/2026 09:05:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 09:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 09:05:23 PM
- iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete • Newsfile • 02/06/2026 02:30:00 PM
- iSpecimen Achieves Rapid Procurement Milestone for Influenza Research • Newsfile • 02/06/2026 01:20:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/03/2026 10:15:10 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2026 05:15:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/27/2026 09:05:25 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/16/2026 09:05:28 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/06/2026 09:30:09 PM
- E.F. Hutton & Co. Acts as Exclusive Placement Agent in iSpecimen Inc.’s ~$5.5 Million Private Placement • GlobeNewswire Inc. • 01/06/2026 03:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 10:15:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 10:06:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:00:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/02/2026 09:30:11 PM
- iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement • GlobeNewswire Inc. • 12/30/2025 07:37:19 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/19/2025 10:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 09:05:28 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
